Skip to main content

Training on Data Use for HIV Program Management in Nigeria

May 03, 2022

Data collection and monitoring is one piece of effective program execution. Equally important are effective interpretation and communication; both are needed to activate the power of data to transform situations and achieve results.

Following the recalibration of HIV estimates based on NAIIS 2018 findings, PEPFAR initiated the Surge strategy in selected states. UMB provides technical expertise and data management services to the IHVN-led Surge project in three states (Rivers, Nasarawa, FCT). UMB has created a functional data system at the facility and community levels for data monitoring and display, using enhanced data wallboards, to support SURGE’s goals.

To build the capacity of the UMB Surge staff to better perform their roles – presenting data with enhanced clarity for decision-making –  the Center for International Health, Education, and Biosecurity (Ciheb) Nigeria conducted a 5-day training workshop from March 14 to 18 in Lagos, Nigeria. The workshop addressed a variety of functionalities, including using Power BI, a data management software application, for data visualization, spatial visualization of data, data quality assessment. Staff are also now empowered to deliver presentations and develop manuscripts using the data.

Post-workshop, Ciheb Nigeria is poised to better fulfill its mandate to meet Surge’s goals and targets more effectively and efficiently—a key development in achieving epidemic control.

Screenshot from data wallboard at a data monitoring center


Center for International Health, Education, and Biosecurity
Institute of Human Virology
Tyler New
Scientific Writer

Related stories

    Tuesday, March 08, 2022

    New CDC Data Reveals Tremendous Impact

    Today the Centers for Disease Control and Prevention (CDC) Division of Global HIV and TB released its 2021 Annual Program Results, presenting an array of impressive data that demonstrate the agency’s impact in fighting infectious diseases. The University of Maryland, Baltimore (UMB), the institution in which Ciheb was founded, began PEPFAR-related work in 2004, and is a proud CDC partner. The 2021 APR numbers are a great reminder of this important work’s impact.

    Thursday, December 16, 2021

    Analytical Database Development Allows for Analysis of Nigerian NDR Data

    Over the last year, Ciheb developed a database that allows policy makers, researchers, and data scientists to analyze anonymized patient-level HIV data from the Nigerian National Data Repository.

    Sunday, September 05, 2021

    Dashboards to Support Nigeria COVID-19 Serosurveillance Study

    In the fall of 2020, Ciheb conducted the first phase of a COVID-19 population-based serosurveillance study (COVID-19 Household Seroprevalance Survey) in the Nigerian states of Enugu, Nasarawa, and Gombe to assess the prevalence of COVID-19 in the country.

    Tuesday, June 29, 2021

    Second Phase of COVID-19 Seroprevalence Survey Underway in Nigeria

    The second phase of a COVID-19 seroprevalence study in Nigeria has begun in Kano State in Northwest Nigeria and the Federal Capital Territory, Abuja. The survey, which was previously conducted in Enugu, Gombe, Lagos, and Nasarawa States in the first phase of the COVID-19 epidemiological survey completed last fall, will help estimate COVID-19 prevalence across the two new states.

    Monday, June 28, 2021

    Ciheb Holds Workshop for Partners, Stakeholders on NDR Implementation in Nigeria

    Ciheb Nigeria, in collaboration with the Federal Ministry of Health (FMOH), recently facilitated a three-day workshop for implementing partners (IPs), key stakeholders, and other parties of interest in the health sector to improve user education, understanding, and efficiency at all levels of the National Data Repository (NDR) implementation.

    Wednesday, May 26, 2021

    Ciheb Supports Vaccine Video Production and Publicity in Nigeria

    The National Primary Health Care Development Agency (NPHCDA) in Nigeria has developed two videos to help educate the public and publicize the rollout of the COVID-19 vaccines.